Victoria University Research Repository (VURR)
metadata only
Aspects of the Pharmaceutical Business Model: Implications for Australia
The business model of the large pharmaceutical companies is complex and has become increasingly so with the technological developments in the industry particularly in relation to the innovations introduced by biotechnology. A business model is not a well defined concept but may be paraphrased as
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- <b>Why Is the PCD Pharma Franchise One of the Fast-Growing Business Opportunities in India?</b>#1145911
- Structural drivers of drug shortages and market withdrawal: a longitudinal analysis of the Romanian pharmaceutical market.#479518
- Business Model Options for Antibiotics: Learning from Other Industries#179782
- Evaluating the Business Case for Continuous Manufacturing of Pharmaceuticals: A Supply Network perspective#1110948
- Alliance Opportunities for Aus Biotech#1026047
Record · ID 1026053
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive